Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Derm-All Matrix is a South Korean biotechnology company specializing in advanced skincare solutions utilizing extracellular matrix (ECM) technology. The company is best known for its "Skin-like" facial masks, which are designed to mimic human skin structure to provide intensive hydration and anti-aging benefits. Their products leverage a proprietary ECM bio-complex that facilitates long-term moisture retention and skin barrier recovery. Derm-All Matrix operates at the intersection of biotechnology and cosmetics, focusing on high-performance dermo-cosmetic applications. The company's technology allows for extended application times, distinguishing its products from traditional hydrogel masks. Their portfolio is primarily focused on dermatological health and aesthetic enhancement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Derm-All Matrix.